Although identification of APPs as biomarkers of disease has not been considered significant, we believe that identification of any protein, regardless of specificity that significantly differs between scrapie affected and healthy controls, will contribute to novel information of underlying pathological processes of scrapie. This evidence concerns the gene CTSB and scrapie.